Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy.
about
RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.Haemopoietic stem cell transplantation for genetic disorders.Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.A novel DDB2-ATM feedback loop regulates human cytomegalovirus replication.Haploidentical stem cell transplantation for children with acute leukaemia.
P2860
Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cytomegalovirus following stem ...... ologic to immunologic therapy.
@ast
Cytomegalovirus following stem ...... ologic to immunologic therapy.
@en
type
label
Cytomegalovirus following stem ...... ologic to immunologic therapy.
@ast
Cytomegalovirus following stem ...... ologic to immunologic therapy.
@en
prefLabel
Cytomegalovirus following stem ...... ologic to immunologic therapy.
@ast
Cytomegalovirus following stem ...... ologic to immunologic therapy.
@en
P2860
P356
P1476
Cytomegalovirus following stem ...... ologic to immunologic therapy.
@en
P2093
Karl S Peggs
P2860
P304
P356
10.1586/14787210.2.4.559
P577
2004-08-01T00:00:00Z